Gene Therapy for "Bubble Boy" Disease
Adenosine deaminase (ADA) deficiency results in the accumulation of toxic metabolites that destroy the immune system, causing severe combined immunodeficiency (ADA SCID) often referred to as the "bubble boy" disease. Strimvelis is a European Medicines Agency approved gene therapy for ADA SCID patients without a suitable bone marrow donor.
Cell